Targacept Initiates Phase 2 Study Of TC-5619 In Cognitive Dysfunction In Schizophrenia (Medical News Today)

December 13, 2009 By

Targacept, Inc.

Read the original here:
Targacept Initiates Phase 2 Study Of TC-5619 In Cognitive Dysfunction In Schizophrenia (Medical News Today)

Filed Under: Recent Domain News Tagged With: alpha7-neuronal, auctions, cognitive-dysfunction, domain, domain-names, domainers, drugs-known, highly-selective, known-as-nnr, new-class, nnr, phase, therapeutics